Type |
Details |
Score |
GXD Expression |
Probe: |
MGI:5519106 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2013-11-22 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1751626 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:5519122 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
2J |
Detected: |
true |
Specimen Num: |
13 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5519106 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2013-11-22 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1751628 |
Pattern: |
Not Specified |
Stage: |
TS28 |
Assay Id: |
MGI:5519122 |
Age: |
postnatal adult |
|
|
Specimen Label: |
1D |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5519106 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2013-11-22 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1761228 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:5519122 |
Age: |
postnatal adult |
|
Note: |
Expression is in vomeronasal sensory neurons. |
Specimen Label: |
4D,D'' |
Detected: |
true |
Specimen Num: |
19 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5519106 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2013-11-22 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1761226 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:5519122 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
2I |
Detected: |
true |
Specimen Num: |
12 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5519106 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2013-11-22 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1760526 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:5519122 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
2I |
Detected: |
true |
Specimen Num: |
12 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5519106 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2013-11-22 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:3559528 |
|
Stage: |
TS28 |
Assay Id: |
MGI:5519122 |
Age: |
postnatal adult |
|
|
Specimen Label: |
1D |
Detected: |
false |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5519108 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2013-11-22 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:5519130 |
Age: |
postnatal adult |
|
|
Specimen Label: |
not shown |
Detected: |
false |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5519106 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2013-11-22 |
Strength: |
Strong |
Sex: |
Not Specified |
Emaps: |
EMAPS:2672026 |
Pattern: |
Not Specified |
Stage: |
TS26 |
Assay Id: |
MGI:5519122 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
2L |
Detected: |
true |
Specimen Num: |
15 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tseng S |
Year: |
1999 |
Journal: |
GenBank Submission |
Title: |
Mus musculus butyrophilin-like protein (Btdc) mRNA, complete cds |
|
|
Pages: |
AF142780 |
|
•
•
•
•
•
|
Publication |
First Author: |
Latchman Y |
Year: |
2001 |
Journal: |
Nat Immunol |
Title: |
PD-L2 is a second ligand for PD-1 and inhibits T cell activation. |
Volume: |
2 |
Issue: |
3 |
Pages: |
261-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tseng SY |
Year: |
2001 |
Journal: |
J Exp Med |
Title: |
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. |
Volume: |
193 |
Issue: |
7 |
Pages: |
839-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ishiwata K |
Year: |
2010 |
Journal: |
J Immunol |
Title: |
Costimulator B7-DC attenuates strong Th2 responses induced by Nippostrongylus brasiliensis. |
Volume: |
184 |
Issue: |
4 |
Pages: |
2086-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Akbari O |
Year: |
2010 |
Journal: |
Mucosal Immunol |
Title: |
PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. |
Volume: |
3 |
Issue: |
1 |
Pages: |
81-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Maazi H |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection. |
Volume: |
8 |
Issue: |
3 |
Pages: |
e59599 |
|
•
•
•
•
•
|
Publication |
First Author: |
Keir ME |
Year: |
2006 |
Journal: |
J Exp Med |
Title: |
Tissue expression of PD-L1 mediates peripheral T cell tolerance. |
Volume: |
203 |
Issue: |
4 |
Pages: |
883-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zuccarino-Catania GV |
Year: |
2014 |
Journal: |
Nat Immunol |
Title: |
CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. |
Volume: |
15 |
Issue: |
7 |
Pages: |
631-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sharpe A |
Year: |
2010 |
Journal: |
MGI Direct Data Submission |
Title: |
Generation of PD-L1/PD-L2 mutant |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wythe SE |
Year: |
2012 |
Journal: |
J Immunol |
Title: |
OX40 ligand and programmed cell death 1 ligand 2 expression on inflammatory dendritic cells regulates CD4 T cell cytokine production in the lung during viral disease. |
Volume: |
188 |
Issue: |
4 |
Pages: |
1647-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2006 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Regulation of T cell activation and tolerance by PDL2. |
Volume: |
103 |
Issue: |
31 |
Pages: |
11695-700 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsumoto K |
Year: |
2008 |
Journal: |
Biochem Biophys Res Commun |
Title: |
B7-DC induced by IL-13 works as a feedback regulator in the effector phase of allergic asthma. |
Volume: |
365 |
Issue: |
1 |
Pages: |
170-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Keir ME |
Year: |
2005 |
Journal: |
J Immunol |
Title: |
Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. |
Volume: |
175 |
Issue: |
11 |
Pages: |
7372-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schreiner B |
Year: |
2008 |
Journal: |
Eur J Immunol |
Title: |
PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. |
Volume: |
38 |
Issue: |
10 |
Pages: |
2706-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Menke J |
Year: |
2007 |
Journal: |
J Immunol |
Title: |
Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. |
Volume: |
179 |
Issue: |
11 |
Pages: |
7466-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Allen SJ |
Year: |
2011 |
Journal: |
J Virol |
Title: |
The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. |
Volume: |
85 |
Issue: |
9 |
Pages: |
4184-97 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liang SC |
Year: |
2006 |
Journal: |
Eur J Immunol |
Title: |
PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. |
Volume: |
36 |
Issue: |
1 |
Pages: |
58-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee RA |
Year: |
2015 |
Journal: |
Ann N Y Acad Sci |
Title: |
Fluorescence tagging and inducible depletion of PD-L2-expressing B-1 B cells in vivo. |
Volume: |
1362 |
|
Pages: |
77-85 |
|
•
•
•
•
•
|
Publication |
First Author: |
Oflazoglu E |
Year: |
2004 |
Journal: |
Eur J Immunol |
Title: |
Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo. |
Volume: |
34 |
Issue: |
12 |
Pages: |
3326-36 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kuipers H |
Year: |
2006 |
Journal: |
Eur J Immunol |
Title: |
Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. |
Volume: |
36 |
Issue: |
9 |
Pages: |
2472-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xiao Y |
Year: |
2014 |
Journal: |
J Exp Med |
Title: |
RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. |
Volume: |
211 |
Issue: |
5 |
Pages: |
943-59 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hirose T |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice. |
Volume: |
12 |
Issue: |
6 |
Pages: |
e0178765 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lázár-Molnár E |
Year: |
2008 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2. |
Volume: |
105 |
Issue: |
30 |
Pages: |
10483-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vogt L |
Year: |
2006 |
Journal: |
J Clin Invest |
Title: |
VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. |
Volume: |
116 |
Issue: |
10 |
Pages: |
2817-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Juneja VR |
Year: |
2017 |
Journal: |
J Exp Med |
Title: |
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. |
Volume: |
214 |
Issue: |
4 |
Pages: |
895-904 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peng C |
Year: |
2019 |
Journal: |
J Immunol |
Title: |
BCL6-Mediated Silencing of PD-1 Ligands in Germinal Center B Cells Maintains Follicular T Cell Population. |
Volume: |
202 |
Issue: |
3 |
Pages: |
704-713 |
|
•
•
•
•
•
|
Publication |
First Author: |
Good-Jacobson KL |
Year: |
2010 |
Journal: |
Nat Immunol |
Title: |
PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. |
Volume: |
11 |
Issue: |
6 |
Pages: |
535-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gao Y |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
TLR2 directing PD-L2 expression inhibit T cells response in Schistosoma japonicum infection. |
Volume: |
8 |
Issue: |
12 |
Pages: |
e82480 |
|
•
•
•
•
•
|
Publication |
First Author: |
McKay JT |
Year: |
2015 |
Journal: |
J Immunol |
Title: |
PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism. |
Volume: |
194 |
Issue: |
5 |
Pages: |
2289-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
McKay JT |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism. |
Volume: |
199 |
Issue: |
6 |
Pages: |
2020-2029 |
|
•
•
•
•
•
|
Publication |
First Author: |
Karunarathne DS |
Year: |
2016 |
Journal: |
Immunity |
Title: |
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity. |
Volume: |
45 |
Issue: |
2 |
Pages: |
333-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hurrell BP |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
PD-L2 controls peripherally induced regulatory T cells by maintaining metabolic activity and Foxp3 stability. |
Volume: |
13 |
Issue: |
1 |
Pages: |
5118 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jaworska K |
Year: |
2015 |
Journal: |
J Immunol |
Title: |
Both PD-1 ligands protect the kidney from ischemia reperfusion injury. |
Volume: |
194 |
Issue: |
1 |
Pages: |
325-33 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pauken KE |
Year: |
2020 |
Journal: |
Cell Rep |
Title: |
The PD-1 Pathway Regulates Development and Function of Memory CD8+ T Cells following Respiratory Viral Infection. |
Volume: |
31 |
Issue: |
13 |
Pages: |
107827 |
|
•
•
•
•
•
|
Publication |
First Author: |
Carter LL |
Year: |
2007 |
Journal: |
J Neuroimmunol |
Title: |
PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. |
Volume: |
182 |
Issue: |
1-2 |
Pages: |
124-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Parekh VV |
Year: |
2009 |
Journal: |
J Immunol |
Title: |
PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells. |
Volume: |
182 |
Issue: |
5 |
Pages: |
2816-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yadav D |
Year: |
2009 |
Journal: |
Cell Immunol |
Title: |
Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice. |
Volume: |
258 |
Issue: |
2 |
Pages: |
161-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gutierrez FR |
Year: |
2011 |
Journal: |
Infect Immun |
Title: |
Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1. |
Volume: |
79 |
Issue: |
5 |
Pages: |
1873-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Belai EB |
Year: |
2014 |
Journal: |
Carcinogenesis |
Title: |
PD-1 blockage delays murine squamous cell carcinoma development. |
Volume: |
35 |
Issue: |
2 |
Pages: |
424-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saha A |
Year: |
2016 |
Journal: |
J Clin Invest |
Title: |
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. |
Volume: |
126 |
Issue: |
7 |
Pages: |
2642-60 |
|
•
•
•
•
•
|
Publication |
First Author: |
Juchem KW |
Year: |
2018 |
Journal: |
J Immunol |
Title: |
PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease. |
Volume: |
200 |
Issue: |
2 |
Pages: |
834-846 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang X |
Year: |
2009 |
Journal: |
J Immunol |
Title: |
A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells. |
Volume: |
182 |
Issue: |
8 |
Pages: |
5123-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ogishi M |
Year: |
2024 |
Journal: |
Immunity |
Title: |
Impaired development of memory B cells and antibody responses in humans and mice deficient in PD-1 signaling. |
Volume: |
57 |
Issue: |
12 |
Pages: |
2790-2807.e15 |
|
•
•
•
•
•
|
Publication |
First Author: |
Francisco LM |
Year: |
2009 |
Journal: |
J Exp Med |
Title: |
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. |
Volume: |
206 |
Issue: |
13 |
Pages: |
3015-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang J |
Year: |
2008 |
Journal: |
Circulation |
Title: |
Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. |
Volume: |
117 |
Issue: |
5 |
Pages: |
660-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hossain MS |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients. |
Volume: |
12 |
Issue: |
9 |
Pages: |
e0184254 |
|
•
•
•
•
•
|
Publication |
First Author: |
Baban B |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
Physiologic control of IDO competence in splenic dendritic cells. |
Volume: |
187 |
Issue: |
5 |
Pages: |
2329-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ou X |
Year: |
2014 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Adaptor protein DOK3 promotes plasma cell differentiation by regulating the expression of programmed cell death 1 ligands. |
Volume: |
111 |
Issue: |
31 |
Pages: |
11431-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Davidson MG |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
In vivo T cell activation induces the formation of CD209(+) PDL-2(+) dendritic cells. |
Volume: |
8 |
Issue: |
10 |
Pages: |
e76258 |
|
•
•
•
•
•
|
Publication |
First Author: |
Grabie N |
Year: |
2007 |
Journal: |
Circulation |
Title: |
Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. |
Volume: |
116 |
Issue: |
18 |
Pages: |
2062-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lázár-Molnár E |
Year: |
2008 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. |
Volume: |
105 |
Issue: |
7 |
Pages: |
2658-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gotsman I |
Year: |
2007 |
Journal: |
J Clin Invest |
Title: |
Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. |
Volume: |
117 |
Issue: |
10 |
Pages: |
2974-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shin T |
Year: |
2003 |
Journal: |
J Exp Med |
Title: |
Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. |
Volume: |
198 |
Issue: |
1 |
Pages: |
31-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ruffner MA |
Year: |
2009 |
Journal: |
Eur J Immunol |
Title: |
B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function. |
Volume: |
39 |
Issue: |
11 |
Pages: |
3084-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao Y |
Year: |
2012 |
Journal: |
Sci China Life Sci |
Title: |
Cross-reactivity of anti-programmed death ligand 2 polyclonal antibody in mouse tissues. |
Volume: |
55 |
Issue: |
11 |
Pages: |
940-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shalapour S |
Year: |
2015 |
Journal: |
Nature |
Title: |
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. |
Volume: |
521 |
Issue: |
7550 |
Pages: |
94-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shalapour S |
Year: |
2017 |
Journal: |
Nature |
Title: |
Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. |
Volume: |
551 |
Issue: |
7680 |
Pages: |
340-345 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gao Y |
Year: |
2013 |
Journal: |
Immunity |
Title: |
Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. |
Volume: |
39 |
Issue: |
4 |
Pages: |
722-32 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fukaya T |
Year: |
2010 |
Journal: |
Blood |
Title: |
Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance. |
Volume: |
116 |
Issue: |
13 |
Pages: |
2266-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huber S |
Year: |
2010 |
Journal: |
Blood |
Title: |
Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. |
Volume: |
116 |
Issue: |
17 |
Pages: |
3311-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matte-Martone C |
Year: |
2011 |
Journal: |
J Immunol |
Title: |
Graft-versus-leukemia (GVL) against mouse blast-crisis chronic myelogenous leukemia (BC-CML) and chronic-phase chronic myelogenous leukemia (CP-CML): shared mechanisms of T cell killing, but programmed death ligands render CP-CML and not BC-CML GVL resistant. |
Volume: |
187 |
Issue: |
4 |
Pages: |
1653-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Okazaki Y |
Year: |
2002 |
Journal: |
Nature |
Title: |
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. |
Volume: |
420 |
Issue: |
6915 |
Pages: |
563-73 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shanghai Model Organisms Center |
Year: |
2017 |
Journal: |
MGI Direct Data Submission |
Title: |
Information obtained from the Shanghai Model Organisms Center (SMOC), Shanghai, China |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wellcome Trust Sanger Institute |
Year: |
2009 |
Journal: |
MGI Direct Data Submission |
Title: |
Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Helmholtz Zentrum Muenchen GmbH |
Year: |
2010 |
Journal: |
MGI Direct Data Submission |
Title: |
Alleles produced for the EUCOMM and EUCOMMTools projects by the Helmholtz Zentrum Muenchen GmbH (Hmgu) |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
UniProt-GOA |
Year: |
2012 |
|
Title: |
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2003 |
|
Title: |
MGI Sequence Curation Reference |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Carninci P |
Year: |
2005 |
Journal: |
Science |
Title: |
The transcriptional landscape of the mammalian genome. |
Volume: |
309 |
Issue: |
5740 |
Pages: |
1559-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
MGD Nomenclature Committee |
Year: |
1995 |
|
Title: |
Nomenclature Committee Use |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
GemPharmatech |
Year: |
2020 |
|
Title: |
GemPharmatech Website. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Skarnes WC |
Year: |
2011 |
Journal: |
Nature |
Title: |
A conditional knockout resource for the genome-wide study of mouse gene function. |
Volume: |
474 |
Issue: |
7351 |
Pages: |
337-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cyagen Biosciences Inc. |
Year: |
2022 |
|
Title: |
Cyagen Biosciences Website. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
UniProt-GOA |
Year: |
2012 |
|
Title: |
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
GOA curators |
Year: |
2016 |
|
Title: |
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
The Gene Ontology Consortium |
Year: |
2010 |
|
Title: |
Automated transfer of experimentally-verified manual GO annotation data to mouse-human orthologs |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
MGI Genome Annotation Group and UniGene Staff |
Year: |
2015 |
Journal: |
Database Download |
Title: |
MGI-UniGene Interconnection Effort |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas |
Year: |
2010 |
|
Title: |
Annotation inferences using phylogenetic trees |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Database and National Center for Biotechnology Information |
Year: |
2000 |
Journal: |
Database Release |
Title: |
Entrez Gene Load |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Allen Institute for Brain Science |
Year: |
2004 |
Journal: |
Allen Institute |
Title: |
Allen Brain Atlas: mouse riboprobes |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Gene 1.0 ST Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI) |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Consensus CDS project |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Group |
Year: |
2003 |
Journal: |
Database Procedure |
Title: |
Automatic Encodes (AutoE) Reference |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bairoch A |
Year: |
1999 |
Journal: |
Database Release |
Title: |
SWISS-PROT Annotated protein sequence database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics |
Year: |
2010 |
Journal: |
Database Release |
Title: |
Protein Ontology Association Load. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and loading genome assembly coordinates from NCBI annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform |
|
|
|
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
247
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Allele |
Name: |
programmed cell death 1 ligand 2; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
programmed cell death 1 ligand 2; endonuclease-mediated mutation 2, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
programmed cell death 1 ligand 2; endonuclease-mediated mutation 3, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|